Summary
Ecolab Inc. (ECL) reported its second quarter 2022 financial results, showing a 13% increase in reported net sales year-over-year, reaching $3.58 billion. This growth was driven by a combination of pricing actions and volume increases across its segments, with fixed currency sales up 17%. Despite topline growth, reported operating income saw a 5% decrease to $425.8 million, and net income attributable to Ecolab declined 1% to $308.3 million. This was primarily due to increased cost of sales, particularly delivered product costs, which more than offset pricing gains. The company is navigating a challenging macroeconomic environment characterized by inflation and supply chain disruptions, which are impacting its gross margins. The company maintained a strong balance sheet with total assets of $21.2 billion and total liabilities of $14.0 billion. Ecolab continues to return capital to shareholders through dividends and share repurchases, demonstrating a commitment to shareholder value. While facing inflationary pressures, Ecolab's diversified business model and strategic pricing initiatives are expected to help mitigate these challenges moving forward.
Financial Highlights
53 data points| Revenue | $3.58B |
| Cost of Revenue | $2.21B |
| Gross Profit | $1.37B |
| SG&A Expenses | $940.10M |
| Operating Income | $425.80M |
| Interest Expense | $57.30M |
| Net Income | $308.30M |
| EPS (Basic) | $1.08 |
| EPS (Diluted) | $1.08 |
| Shares Outstanding (Basic) | 285.10M |
| Shares Outstanding (Diluted) | 286.60M |
Key Highlights
- 1Reported net sales increased 13% to $3.58 billion in Q2 2022 compared to Q2 2021.
- 2Fixed currency sales grew 17% year-over-year, indicating strong underlying business performance.
- 3Reported operating income decreased 5% to $425.8 million, impacted by rising cost of sales.
- 4Net income attributable to Ecolab was $308.3 million, a slight decrease of 1% year-over-year.
- 5Diluted EPS remained flat at $1.08 for the quarter.
- 6The company is actively managing its capital structure, with $8.8 billion in total debt and $124.9 million in cash and cash equivalents as of June 30, 2022.
- 7Ecolab experienced significant growth in its Global Healthcare & Life Sciences segment, with fixed currency sales up 37%, largely due to the Purolite acquisition.